|4Apr 10, 5:26 PM ET

Ohri Manu 4

4 · GT Biopharma, Inc. · Filed Apr 10, 2023

Insider Transaction Report

Form 4
Period: 2023-04-06
Ohri Manu
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-04-06$0.50/sh+50,000$25,00050,000 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Anarjay Concepts, Inc.)
    100,000

Documents

1 file
  • 4
    ownership.xmlPrimary